Cabergoline Tablets Market Analysis: Emerging Applications and Forecast
The Cabergoline Tablets Market is expanding as awareness and diagnosis of hormonal and endocrine conditions continue to increase. The market was valued at USD 400 million in 2024 and is projected to reach USD 800 million by 2035, growing at a 6.3% CAGR during 2025–2035. Pharmaceutical companies are focusing on improving tablet formulations, product quality, and patient convenience. Wider...
0 Comments 0 Shares 125 Views 0 Reviews